Douglas Boothe
CIK 1566118 · President and CEO · last filed 2026-04-21
Douglas Boothe is a President and CEO who has filed 16 SEC Form 4 insider transactions across 3 companies since 2013. Current disclosed insider exposure totals $8.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.8K
3
16
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKORN INC (AKRX) Delisted | President and CEO | 466,261 | — | — | $0 | 2 | 2020-01-10 |
| Impax Laboratories, LLC (IPXL) Delisted | President, Generics Division | 78,549 | — | — | $0 | 4 | 2018-03-05 |
| PRGO | EVP & GM Perrigo Pharma | 803 | $10.99 | $8.8K | $0 | 8 | 2016-03-01 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-21 | — | Grant (A) | — | $0 | |
| 2020-01-10 | AKORN INC (AKRX) Delisted | Tax (F) | −41,353 | -$51.7K | EDGAR |
| 2019-01-08 | AKORN INC (AKRX) Delisted | Grant (A) | +507,614 | $0 | EDGAR |
| 2018-05-08 | — | Disp (D) | −55,901 | $0 | |
| 2018-03-05 | Impax Laboratories, LLC (IPXL) Delisted | Tax (F) | −2,041 | -$39.8K | EDGAR |
| 2017-08-02 | Impax Laboratories, LLC (IPXL) Delisted | Tax (F) | −5,282 | -$94.3K | EDGAR |
| 2017-03-06 | Impax Laboratories, LLC (IPXL) Delisted | Grant (A) | +23,272 | $0 | EDGAR |
| 2016-08-31 | Impax Laboratories, LLC (IPXL) Delisted | Grant (A) | +62,600 | $0 | EDGAR |
| 2016-03-01 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2015-08-25 | PRGO | Mixed | +802 | $149.9K | EDGAR |